<code id='0828EEC0F0'></code><style id='0828EEC0F0'></style>

<acronym id='0828EEC0F0'></acronym>

<center id='0828EEC0F0'><center id='0828EEC0F0'><tfoot id='0828EEC0F0'></tfoot></center><abbr id='0828EEC0F0'><dir id='0828EEC0F0'><tfoot id='0828EEC0F0'></tfoot><noframes id='0828EEC0F0'>

<optgroup id='0828EEC0F0'><strike id='0828EEC0F0'><sup id='0828EEC0F0'></sup></strike><code id='0828EEC0F0'></code></optgroup>

<b id='0828EEC0F0'><label id='0828EEC0F0'><select id='0828EEC0F0'><dt id='0828EEC0F0'><span id='0828EEC0F0'></span></dt></select></label></b><u id='0828EEC0F0'></u>

~~<i id='0828EEC0F0'><strike id='0828EEC0F0'><tt id='0828EEC0F0'><pre id='0828EEC0F0'></pre></tt></strike></i>~~

Home» knowledge» leisure time

leisure time

leisure time

author：hotspot 2025-10-02 16:55:27 Page View：543

STAT Q&A — Paul Matteis (right), in 2017 with then-colleagues Seamus Fernandez (far left) Geoffrey Porges. Alex Hogan/STAT

NEW YORK — Is biotech having a renaissance in neuroscience? Can we solve the placebo effect? And what’s going to happen next year?

Paul Matteis, co-head of biotech research at Stifel, sat down with STAT at the firm’s annual health care conference here to field those questions and opine on how management teams can walk the delicate balance between hype and sandbagging. This transcript has been edited for length and clarity.

advertisement

One thing I’ve been hearing lately is that biotech has entered a sort of renaissance in neuroscience. Do you agree with that?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Teladoc has a new CEO, but challenges remain the same
Next article： Heart attack and stroke risk calculators need revising

explore

Cancer drug shortages should be causing more outrage

Cancer drug shortages should be causing more outrage

DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

DarronCummings/APScientistsattheFoodandDrugAdministrationhavetwobigquestionsaboutEliLilly’sexperimen

Affirmative action in medical school literally saved lives

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Readers discuss the intersection of pregnancy and addiction

MollyFergusonforSTATFirstOpinionisSTAT’splatformforinteresting,illuminating,andmaybeevenprovocativea

read more